Report: Bayer Delayed Warning on Cholesterol Drug  NEW YORK (Reuters) - Bayer AG may have known its withdrawn  cholesterol-lowering drug Baycol caused a high rate of a  serious muscle condition more than a year before it added a  warning to its label, according to a prominent medical journal.